Visual loss in giant cell arteritis 3 weeks after steroid initiation
File(s)LeGoueff_November_2018_casereport_revision1.pdf (526.6 KB)
Accepted version
Author(s)
Le Goueff, Anouk
Peters, James
Willcocks, Lisa
Jayne, David
Type
Journal Article
Abstract
Giant cell arteritis (GCA) is the most common vasculitis in adults and blindness is a common complication if left untreated. Oral glucocorticoids are the mainstay of treatment and if started promptly, loss of vision can usually be prevented. We present the case of a 77-year-old man who developed irreversible bilateral blindness after a confirmed diagnosis of GCA and oral steroid treatment. The roles of diagnostic delay, steroid dosing, significance of visual symptoms at diagnosis and after commencing oral glucocorticoids, and interpretation of ophthalmological signs are reviewed.
Date Issued
2019-03-06
Date Acceptance
2019-02-01
Citation
BMJ Case Reports, 2019, 12 (3), pp.e228251-e228251
ISSN
1757-790X
Publisher
BMJ Publishing Group
Start Page
e228251
End Page
e228251
Journal / Book Title
BMJ Case Reports
Volume
12
Issue
3
Copyright Statement
© BMJ Publishing Group Limited 2019. No commercial re-use. See rights and permissions. Published by BMJ. This article has been accepted for publication in BMJ Case Reports following peer review. The definitive copyedited, typeset version Le Goueff A, Peters J, Willcocks L, et alVisual loss in giant cell arteritis 3 weeks after steroid initiationBMJ Case Reports CP 2019;12:e228251 is available online at: http://dx.doi.org/10.1136/bcr-2018-228251
Identifier
https://casereports.bmj.com/content/12/3/e228251
Subjects
1103 Clinical Sciences
Publication Status
Published
Date Publish Online
2019-03-06